Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess Longer-term Opioid Medication Effectiveness (SALOME)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
General Inclusion Criteria:~* Regular use of opioids for five years~* Injecting opioids in the past year~* Two attempts at treatment including one methadone (or other substitution)~* Must be a legal adult~* Struggling with drug related problems~General Exclusion Criteria:~* Pregnancy upon study entry~* Diagnosis of severe medical or psychiatric conditions contra-indicated for diacetylmorphine or hydromorphone treatment.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hydromorphone (Type: EXPERIMENTAL): Phase I: Injectable Hydromorphone is received for 6 months of the study. Phase II: At 6 months, participants are randomized to either: 1) stay on injectable hydromorphone; or 2) switch to oral hydromorphone, for another six months.
- Diacetylmorphine (Type: ACTIVE_COMPARATOR): Phase I: Injectable Diacetylmorphine is received for 6 months of the study. Phase II: At 6 months, participants are randomized to either: 1) stay on injectable Diacetylmorphine; or 2) switch to oral Diacetylmorphine, for another six months.

Based on this trial design, predict the completion outcome and termination type (if applicable).